The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

CompletedOBSERVATIONAL
Timeline

Start Date

September 30, 2006

Conditions
HIV Infections
Trial Locations (1)

21224

National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT01034800 - The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215 | Biotech Hunter | Biotech Hunter